Asset Details
Do you wish to reserve the book?
Why tough regulations are good news: ANALYST'S VIEWPOINT: Many chemical producers, however, fear the cost of change, says Alex Comer, chemicals analyst at HSBC
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Why tough regulations are good news: ANALYST'S VIEWPOINT: Many chemical producers, however, fear the cost of change, says Alex Comer, chemicals analyst at HSBC
Do you wish to request the book?
Why tough regulations are good news: ANALYST'S VIEWPOINT: Many chemical producers, however, fear the cost of change, says Alex Comer, chemicals analyst at HSBC
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Newspaper Article
Why tough regulations are good news: ANALYST'S VIEWPOINT: Many chemical producers, however, fear the cost of change, says Alex Comer, chemicals analyst at HSBC
2003
Overview
Unlike the oil industry, where price is \"regulated\" by Opec at levels that demand wouldn't justify, or the pharmaceutical industry, where \"regulations\" (patents and approvals) can act as a licence to make money, the chemical industry is, for the most part, exposed to the harsh wind of undistorted competition. Nor is agrochemicals the only example of the deliberate expansion of the industry into regulated areas. The heavy investment both organically and via M&A in pharmaceutical manufacturing assets by many (Lonza, DSM, Clariant, Rhodia and Degussa) in the chemical industry in the late 1990s was driven, in part, by the security that FDA plant approval and cGMP status afforded the assets. Environmental regulations introduced in the early 1990s demanded significant reductions in the use of solvents and volatile organic components. Although resisted at the time, these regulations had a number of positive effects. Ciba Speciality Chemicals attributes some of its reduced capital requirements to reduced need for expensive effluent plant.
Publisher
The Financial Times Limited
